Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 250 | 1,612 | 1,849 | 1,455 | 2,319 |
| Gross Profit | 250 | 1,612 | 1,849 | 1,455 | 2,319 |
| Operating Expenses | 68,795 | 79,693 | 60,696 | 116,739 | 50,142 |
| Operating Income | -68,545 | -78,081 | -58,847 | -115,284 | -47,823 |
| Other Income | 4,059 | 4,204 | 2,700 | 762 | 370 |
| Pre-tax Income | -64,486 | -73,877 | -56,147 | -114,522 | -47,453 |
| Income Tax | N/A | -1,250 | N/A | -775 | N/A |
| Net Income Continuous | -64,486 | -72,627 | -56,147 | -113,747 | -47,453 |
| Net Income | $-64,486 | $-72,627 | $-56,147 | $-113,747 | $-47,453 |
| EPS Basic Total Ops | -10.10 | -11.80 | -12.90 | -31.40 | -18.60 |
| EPS Basic Continuous Ops | -10.06 | -11.83 | -12.86 | -31.38 | -18.62 |
| EPS Diluted Total Ops | -10.10 | -11.80 | -12.90 | -31.40 | -18.60 |
| EPS Diluted Continuous Ops | -10.06 | -11.83 | -12.86 | -31.38 | -18.62 |
| EPS Diluted Before Non-Recurring Items | -10.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-66,077 | $-71,307 | $-56,158 | $-52,967 | $-46,231 |